David Roman
Stock Analyst at Goldman Sachs
(1.38)
# 3,474
Out of 4,455 analysts
238
Total ratings
50.4%
Success rate
-0.4%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Maintained: Buy | $95 → $98 | $90.78 | +7.95% | 18 | Jun 15, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $558 | $404.70 | +37.88% | 21 | Jun 15, 2026 | |
| OMDA Omada Health | Maintained: Buy | $26 → $25 | $20.89 | +19.67% | 7 | Jun 10, 2026 | |
| MDT Medtronic | Maintained: Hold | $84 → $83 | $80.98 | +2.49% | 12 | Jun 4, 2026 | |
| MMED MiniMed Group | Maintained: Buy | $14 → $24 | $14.24 | +68.54% | 2 | Jun 3, 2026 | |
| MOBI Mobia Medical | Initiated Coverage: Buy | $31 | $14.63 | +111.89% | 1 | Jun 1, 2026 | |
| ABT Abbott Laboratories | Maintained: Buy | $121 → $113 | $94.12 | +20.06% | 13 | May 31, 2026 | |
| HQY HealthEquity | Maintained: Sell | $89 → $88 | $88.46 | -0.52% | 5 | May 29, 2026 | |
| BSX Boston Scientific | Rated: Buy | $84 → $71 | $44.23 | +60.52% | 10 | May 27, 2026 | |
| COO The Cooper Companies | Maintained: Sell | $73 → $61 | $71.02 | -14.11% | 5 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $237 → $205 | $158.25 | +29.54% | 6 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $21 | $16.24 | +29.31% | 6 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $8 | $8.39 | -4.65% | 8 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $17 | $16.82 | +1.07% | 6 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $153 | $144.42 | +5.94% | 4 | May 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $70.14 | +14.06% | 5 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $28 → $24 | $20.88 | +14.94% | 8 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $22.79 | -12.24% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $73 → $72 | $83.43 | -13.70% | 8 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 → $50 | $38.87 | +28.63% | 3 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $54 → $66 | $79.53 | -17.01% | 2 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $16 | $11.76 | +36.05% | 8 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 | $22.04 | -22.87% | 19 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $357 → $361 | $332.71 | +8.50% | 11 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $147 | $118.89 | +23.64% | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $65.76 | - | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $192 → $167 | $155.92 | +7.11% | 5 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $24 → $17 | $26.43 | -35.68% | 7 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 | $16.32 | +16.42% | 3 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $93 → $88 | $93.10 | -5.48% | 8 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $39 → $29 | $77.29 | n/a | 3 | May 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $18 → $21 | $86.25 | n/a | 3 | May 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $103 | $109.37 | n/a | 1 | Nov 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $44 → $15 | $7.47 | n/a | 2 | Aug 30, 2012 |
Edwards Lifesciences
Jun 15, 2026
Maintained: Buy
Price Target: $95 → $98
Current: $90.78
Upside: +7.95%
Intuitive Surgical
Jun 15, 2026
Reiterated: Buy
Price Target: $558
Current: $404.70
Upside: +37.88%
Omada Health
Jun 10, 2026
Maintained: Buy
Price Target: $26 → $25
Current: $20.89
Upside: +19.67%
Medtronic
Jun 4, 2026
Maintained: Hold
Price Target: $84 → $83
Current: $80.98
Upside: +2.49%
MiniMed Group
Jun 3, 2026
Maintained: Buy
Price Target: $14 → $24
Current: $14.24
Upside: +68.54%
Mobia Medical
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $31
Current: $14.63
Upside: +111.89%
Abbott Laboratories
May 31, 2026
Maintained: Buy
Price Target: $121 → $113
Current: $94.12
Upside: +20.06%
HealthEquity
May 29, 2026
Maintained: Sell
Price Target: $89 → $88
Current: $88.46
Upside: -0.52%
Boston Scientific
May 27, 2026
Rated: Buy
Price Target: $84 → $71
Current: $44.23
Upside: +60.52%
The Cooper Companies
May 27, 2026
Maintained: Sell
Price Target: $73 → $61
Current: $71.02
Upside: -14.11%
May 27, 2026
Maintained: Buy
Price Target: $237 → $205
Current: $158.25
Upside: +29.54%
May 27, 2026
Maintained: Hold
Price Target: $25 → $21
Current: $16.24
Upside: +29.31%
May 27, 2026
Maintained: Buy
Price Target: $7 → $8
Current: $8.39
Upside: -4.65%
May 27, 2026
Maintained: Buy
Price Target: $20 → $17
Current: $16.82
Upside: +1.07%
May 25, 2026
Reiterated: Buy
Price Target: $153
Current: $144.42
Upside: +5.94%
May 15, 2026
Maintained: Buy
Price Target: $80
Current: $70.14
Upside: +14.06%
May 15, 2026
Rated: Hold
Price Target: $28 → $24
Current: $20.88
Upside: +14.94%
May 13, 2026
Maintained: Buy
Price Target: $20
Current: $22.79
Upside: -12.24%
May 6, 2026
Maintained: Hold
Price Target: $73 → $72
Current: $83.43
Upside: -13.70%
May 6, 2026
Maintained: Buy
Price Target: $54 → $50
Current: $38.87
Upside: +28.63%
May 5, 2026
Maintained: Sell
Price Target: $54 → $66
Current: $79.53
Upside: -17.01%
May 5, 2026
Maintained: Buy
Price Target: $17 → $16
Current: $11.76
Upside: +36.05%
May 1, 2026
Maintained: Hold
Price Target: $17
Current: $22.04
Upside: -22.87%
May 1, 2026
Maintained: Hold
Price Target: $357 → $361
Current: $332.71
Upside: +8.50%
Apr 30, 2026
Maintained: Hold
Price Target: $147
Current: $118.89
Upside: +23.64%
Apr 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $65.76
Upside: -
Apr 10, 2026
Initiated Coverage: Hold
Price Target: $192 → $167
Current: $155.92
Upside: +7.11%
Apr 9, 2026
Rated: Hold
Price Target: $24 → $17
Current: $26.43
Upside: -35.68%
Mar 23, 2026
Maintained: Hold
Price Target: $19
Current: $16.32
Upside: +16.42%
Feb 10, 2026
Maintained: Sell
Price Target: $93 → $88
Current: $93.10
Upside: -5.48%
May 16, 2016
Upgraded: Hold
Price Target: $39 → $29
Current: $77.29
Upside: n/a
May 16, 2016
Downgraded: Sell
Price Target: $18 → $21
Current: $86.25
Upside: n/a
Nov 15, 2013
Maintained: Sell
Price Target: $103
Current: $109.37
Upside: n/a
Aug 30, 2012
Maintained: Hold
Price Target: $44 → $15
Current: $7.47
Upside: n/a